Head-to-head · free
TScan Therapeutics, Inc. vs Tenon Medical, Inc.
TCRX vs TNON — return on capital, cash generation, margins and balance sheet side by side.
TCRX
2 / 8
measures where TCRX leads
TNON
6 / 8
measures where TNON leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | TCRX · FY2025 | TNON · FY2025 |
|---|---|---|
| Revenue | $10.3M | $3.9M |
| Net income | (129.8M) | (12.6M) |
| Revenue growth (yearly, multi-year) | 0.5% | 78.7% |
| Free cash flow | (139.7M) | (11.0M) |
| Free cash flow margin | -1353.3% | -279.4% |
| Net cash / (debt) | — | — |
| ROIC | — | — |
| Return on equity | -71.3% | -600.0% |
| Gross margin | — | 59.8% |
| Operating margin | -1315.4% | -324.3% |
| Net debt / EBITDA | 0.90x | 0.31x |
Figures are as reported by each company; latest fiscal year shown.
Where TScan Therapeutics, Inc.'s cash went (FY2025)
- Capital spending
- $4.4M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Tenon Medical, Inc.'s cash went (FY2025)
- Capital spending
- $273000
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free